Notice of Change to PAS-19-317 "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)"

Notice Number: NOT-AG-19-035

Key Dates
Release Date: July 29, 2019

Related Announcements
PAS-19-317

Issued by
National Institute on Aging (NIA)

Purpose

This Notice informs the research community that the open date (earliest submission date) and first application due date for Funding Opportunity Announcement PAS-19-317 "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" have changed as indicated below.

Part 1. Overview Information, Key Dates
Currently Reads:

Open Date (Earliest Submission Date): December 05, 2019

Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is January 5, 2020.

Revised to Read:

Open Date (Earliest Submission Date): August 5, 2019

Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is September 5, 2019.

 

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Zane Martin, Ph.D.
National Institute on Aging (NIA)
Division of Neuroscience (DN)
Telephone: 301-827-7130
Email: zane.martin@nih.gov

Michael-David ARR Kerns, M.M., M.S., Ph.D.
National Institute on Aging (NIA)
NIA SBIR-STTR Program Coordinator
Telephone: 301-402-7713
Email: kernsmd@mail.nih.gov)